Company / Tangible Book Value per Share
REGENXBIO Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.07
FY2025
5-year range
$2.07 / $12.05
FY2021-FY2025
Trend
-64.8%
vs FY2024
Sector context
#142 of 209
Health Care
What the data says
At $2.07, REGENXBIO Inc.'s tangible book value per share ranks #142 of 209 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $12.05 in FY2022 to $2.07 in FY2025.
Based on SEC 10-K filings.
2.07 in FY2025 with a 5-year CAGR of -31.5%.
Declined from $7.20 to $2.07 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -44.4%
- 5-Year CAGR
- -31.5%
- 10-Year CAGR
- -
Sector benchmark
#142 of 209 in Health CareTop 68% of 209This company $2.07 Sector average $119.74
▼
-98.3% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 64.8% year-over-year.
- Ranks #142 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.07 | -64.8% |
| FY2024 | $5.89 | -18.1% |
| FY2023 | $7.20 | -40.3% |
| FY2022 | $12.05 | +0.3% |
| FY2021 | $12.01 | -12.7% |
| FY2020 | $13.76 | +171.5% |
| FY2019 | $5.07 | -68.8% |
| FY2018 | $16.26 | +135.2% |
| FY2017 | $6.91 | +1094.5% |
| FY2016 | -$0.70 | +86.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026